Subscribe

iShares Global Healthcare ETF (IXJ.AX)

AUD141.34 -0.12 (-0.08%)
ASX AUD AU Equity
NAV AUD 141.07 +0.19% vs NAV as of 2026-07-13
AUM AUD 1.43B
TER 0.41%
Yield (TTM) 1.60%
Distribution Distributing · Semi-Annual
52-week range 124.81 – 150.91
Holdings 126
Issuer IShares

About this ETF

IXJ offers marketlike exposure to global pharmaceutical, biotechnology, and medical device companies. The fund pulls from the S&P Global 1200 universe, which effectively screens out small-caps, giving the fund a large-cap tilt compared to our benchmark. Aside from that, geographic and sector weights look neutral and make it a viable entry-point to global healthcare. BlackRock Fund Advisors uses a sampling approach to indexing. This means the fund may not hold all the stocks of the underlying index but will hold securities that collectively have the same investment profile. Stocks within IXJ are selected and weighted by float-adjusted market-cap. The index is rebalanced quarterly.

ISIN AU000000IXJ9
Issuer IShares
Domicile AU
Inception 2001-11-13
Asset class Equity

Price

Top 10 holdings

ELI LILLY LLY 10.74%
JOHNSON & JOHNSON JNJ 7.07%
ABBVIE INC ABBV 5.01%
UNITEDHEALTH GROUP INC UNH 4.45%
MERCK & CO INC MRK 3.92%
ROCHE PS PAR AG ROP.SW 3.76%
NOVARTIS AG NOVN.SW 3.62%
ASTRAZENECA PLC AZN.L 3.43%
AMGEN INC AMGN 2.52%
THERMO FISHER SCIENTIFIC INC TMO 2.52%
See full holdings →